Literature DB >> 11338118

Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.

J Evans1, R M Chalmers, H Chart, R L Salmon, S M Kench, T J Coleman, D Meadows, P Morgan-Capner, P Softley, M Sillis, D R Thomas.   

Abstract

The techniques of enzyme-linked immunosorbent assay (ELISA) and immunoblotting were used to examine a total of 1667 sera, from apparently healthy members of rural communities in England, for antibodies to the lipopolysaccharide (LPS) of Escherichia coli O157 and Verocytotoxins (VT). Twenty-nine sera from 22 individuals were shown to have antibodies specific for E. coli O157 LPS. Some of these lived on livestock farms and had occupational contact with cattle, suggesting that personnel working with farm animals may produce serum antibodies to the O157 LPS antigens. Fifteen people had IgG class antibodies to O157 LPS, suggesting long-term exposure to E. coli O157 and five people had serum antibodies on more than one occasion showing evidence of persistent antibodies to O157 LPS. Thirteen sera from 12 of 22 individuals also contained antibodies to VT1, VT2 or both toxins. Ten sera contained antibodies to VT1 and VT2, three sera contained antibodies to VT2 only.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11338118     DOI: 10.1023/a:1011072907877

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Bacterial antigenic cross-reactions and haemolytic uraemic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

3.  A rapid immunoblotting procedure for detecting serum antibodies to the lipopolysaccharide of Escherichia coli O157.

Authors:  H Chart; S Montgomery; B Rowe
Journal:  Lett Appl Microbiol       Date:  1994-02       Impact factor: 2.858

4.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.

Authors:  A Thomas; T Cheasty; J A Frost; H Chart; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

5.  Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Authors:  H Chart; H R Smith; S M Scotland; B Rowe; D V Milford; C M Taylor
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

6.  Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source.

Authors:  P A Chapman; D J Wright; P Norman
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

7.  The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.

Authors:  H Chart; T Cheasty; D Cope; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

8.  Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man.

Authors:  P A Chapman; C A Siddons; D J Wright; P Norman; J Fox; E Crick
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

9.  The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.

Authors:  M Bitzan; K Ludwig; M Klemt; H König; J Büren; D E Müller-Wiefel
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  3 in total

1.  Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans.

Authors:  H Toshima; M Hachio; Y Ikemoto; J Ogasawara; A Hase; K Takahashi; H Masaki; Y Nishikawa
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

Review 2.  Subclinical infection and asymptomatic carriage of gastrointestinal zoonoses: occupational exposure, environmental pathways, and the anonymous spread of disease.

Authors:  R S Quilliam; P Cross; A Prysor Williams; G Edwards-Jones; R L Salmon; D Rigby; R M Chalmers; D Rh Thomas; D L Jones
Journal:  Epidemiol Infect       Date:  2013-05-10       Impact factor: 4.434

3.  Fecal diagnostics in combination with serology: best test to establish STEC-HUS.

Authors:  Kioa L Wijnsma; Sheila A M van Bommel; Thea van der Velden; Elena Volokhina; Michiel F Schreuder; Lambertus P van den Heuvel; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2016-05-30       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.